December 16, 2016 Selvita to present at Biotech Showcase 2017 in San Francisco
Read More
November 30, 2016 Selvita presents posters at 2016 EORTC-NCI-AACR Symposium
Read More
August 18, 2016 FDA has accepted Selvita’s IND application for the SEL24 Phase I/II clinical trial in AML
Read More
August 18, 2016 FDA has accepted Selvita’s IND application for the SEL24 Phase I/II clinical trial in AML
Read More
July 28, 2016 Epidarex Capital Creates Nodthera Limite
Read More
June 6, 2016 Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory
Read More
February 1, 2016 Selvita will present at the 18th Annual BIO CEO & Investor Conference 2016
Read More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok Privacy policy